Current treatment landscape for relapsed and/or refractory multiple myeloma

Meletios A Dimopoulos; Paul G. Richardson; Philippe Moreau; Kenneth C. Anderson

doi:10.1038/nrclinonc.2014.200

Related publications

Article2010

Emerging therapies for the treatment of relapsed or refractory multiple myeloma

Meletios A Dimopoulos, Jesús F. San Miguel, Kenneth C. Anderson

Article2015

Treatment options for relapsed and refractory multiple myeloma

Ajay K. Nooka, Efstathios Kastritis, Meletios A Dimopoulos, Sagar Lonial

Article2009

Treatment of Relapsed/Refractory Multiple Myeloma

Efstathios Kastritis, Antonio Palumbo, Meletios A Dimopoulos

Article2015

Elotuzumab Therapy for Relapsed or Refractory Multiple Myeloma

Sagar Lonial, Meletios A Dimopoulos, Antonio Palumbo, Darrell White, Sebastian Grosicki, Ivan Špıčka, Adam Walter‐Croneck, Philippe Moreau, María‐Victoria Mateos, Hila Magen, Andrew R. Belch, Donna Reece, Meral Beksaç, Andrew Spencer, Heather Oakervee, Robert Z. Orlowski, Masafumi Taniwaki, Christoph Röllig, Hermann Einsele, Ka Lung Wu, Anil Singhal, Jesús F. San Miguel, Morio Matsumoto, Jessica Katz, Eric Bleickardt,

Article2007

Lenalidomide plus Dexamethasone for Relapsed or Refractory Multiple Myeloma

Meletios A Dimopoulos, Andrew Spencer, Michael Attal, H. Miles Prince, Jean‐Luc Harousseau, Anna Dmoszyńska, Jesús F. San Miguel, Andrzej Hellmann, Thierry Façon, Robin Foà, Alessandro Corso, Zvenyslava Masliak, Marta Olesnyckyj, Zhinuan Yu, John Patin, Jerome B. Zeldis, Robert Knight